ABL1, actif, son humain étiqueté PRECISIO, recombinant, exprimé en cellules bactériulovirus infectées par le Sf9, > = 70 % (SDS-PAGE), solution de glycérol aqueuse tamponnée

Code: srp5279-10ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

ABL1 protooncogene encodes a cytoplasmic and nuclear protein tyrosine kinase that has been implicated in processes of cell differentiation, cell division,...


en savoir plus

Votre prix
£436.00 10UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

ABL1 protooncogene encodes a cytoplasmic and nuclear protein tyrosine kinase that has been implicated in processes of cell differentiation, cell division, cell adhesion, and stress response. Activity of ABL protein is negatively regulated by its SH3 domain and deletion of the SH3 domain turns ABL1 into an oncogene. Translocation and head-to-tail fusion of the BCR and ABL1 genes is present in many cases of chronic myelogeneous leukemia. The DNA-binding activity of the ubiquitously expressed ABL1 tyrosine kinase is regulated by CDK1-mediated phosphorylation, suggesting a cell cycle function for ABL1.

Legal Information

PRECISIO is a registered trademark of Sigma-Aldrich Co. LLC

Physical form

Supplied in 50 mM sodium phosphate, pH 7.0, 300 mM NaCl, 150 mM imidazole, 0.1 mM PMSF, 0.2 mM DTT, 25% glycerol.

Preparation Note

After opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles.

application(s)genomic analysis
assay≥70% (SDS-PAGE)
biological sourcehuman
formbuffered aqueous glycerol solution
Gene Informationhuman ... ABL1(25)
mol wt~135 kDa
NCBI accession no.NM_005157
product linePRECISIO®
recombinantexpressed in baculovirus infected Sf9 cells
shipped indry ice
specific activity663-1024 nmol/min·mg
storage temp.−70°C
Ce produit répond aux critères suivants: